Teva previews “Pivot to Growth” at the J.P. Morgan Healthcare Conference

Teva ($TEVA) said CEO Richard Francis will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 (8:15am PT). Teva plans to discuss:

* Progress on its “Pivot to Growth” strategy (generics cash flow funding innovation)

* Growth drivers from key brands AUSTEDO, AJOVY, and UZEDY

* Pipeline focus (including olanzapine LAI, DARI (ICS/SABA), duvakitug (anti-TL1A), emrusolmin, anti-IL-15)

* Expected 2025 performance and a forward-looking outlook for 2026 and beyond, including disciplined capital allocation and a goal of reaching an investment-grade credit profile

Why this matters for traders

* JPM Healthcare week is a major “management narrative” catalyst: guidance tone, KPIs, and pipeline tim ...